ข้ามไปยังเนื้อหา

Émile van Ermengem: The Bacterial Origin of Botulism

เนื้อหานี้ยังไม่มีในภาษาของคุณ

Émile Pierre-Marie van Ermengem (1851–1932) was a Belgian bacteriologist at the University of Ghent who established the bacterial and toxin origin of a foodborne botulism outbreak in Ellezelles, Belgium. His investigation of the December 1895 outbreak identified an anaerobic bacterium—one that grows without oxygen—which he named Bacillus botulinus, later known as Clostridium botulinum (Van Ermengem biography — Ghent University 🔗).

His contribution encompassed both the organism and the poisonous substance it produced. It was a foundation of botulinum toxin research, rather than the development of a pharmaceutical product. Edward J. Schantz and Alan B. Scott belong to the later purification and therapeutic-development history (Historical notes on botulism and therapeutic toxin use — Movement Disorders 🔗).

QuestionAnswer
What did Émile van Ermengem discover?He isolated the bacterium associated with the Ellezelles outbreak and linked the illness to its toxin.
Did he discover Botox?No. Identifying a toxin-producing organism was an earlier scientific contribution, separate from developing a regulated medicine.
What name did he give the organism?Bacillus botulinus, the original name behind Clostridium botulinum.
Why do accounts give different years?The outbreak occurred in 1895, an initial report is dated 1896, and the detailed German-language paper appeared in 1897.
FieldDetail
Full nameÉmile Pierre-Marie van Ermengem
Life dates1851–1932
Professional fieldBacteriology
InstitutionUniversity of Ghent
Historical eventDecember 1895 botulism outbreak in Ellezelles, Belgium
Original organism nameBacillus botulinus
Modern connectionClostridium botulinum and the bacterial origin of botulism

Ghent University’s institutional record dates his first appointment to 1885 and his full professorship to 1888. He directed its bacteriology laboratory from 1886 to 1914, placing the Ellezelles investigation within an established academic microbiology career (Van Ermengem institutional record — UGentMemorialis 🔗).

On December 14, 1895, local musicians attended a funeral in Ellezelles and then shared a meal that included preserved ham. Several became seriously ill and three died. Local doctors suspected the ham and asked van Ermengem to investigate. Ghent University’s historical account connects his examination of the remaining food and material from the victims with the identification of the bacterium and its toxin (Ellezelles investigation — Ghent University 🔗).

The important distinction was between the bacterium and the toxin it produced. In foodborne botulism, illness follows ingestion of toxin already present in food; bacteria do not have to establish an infection in the patient for that poisoning to occur. This is the modern public-health definition used by Italy’s national health institute (What is foodborne botulism? — Istituto Superiore di Sanità 🔗).

That explanation should not be extended to every form of botulism. In wound and infant botulism, toxin can instead be produced after the bacteria grow in a wound or the intestine (About botulism — CDC 🔗). The Ellezelles investigation concerned foodborne poisoning.

These dates refer to different parts of the investigation and publication record:

DateEventEvidence
December 14, 1895The funeral meal associated with the Ellezelles outbreak.Ghent University historical account 🔗
1896An early report, Untersuchungen über Fälle von Fleischvergiftung mit Symptomen von Botulismus, is the original publication listed for the name Bacillus botulinus.Bacillus botulinus nomenclature record — LPSN 🔗
February 1897The detailed paper Ueber einen neuen anaëroben Bacillus und seine Beziehungen zum Botulismus appeared in volume 26, pages 1–56.Original paper record — Springer Nature 🔗

The often-cited English version, A New Anaerobic Bacillus and Its Relation to Botulism, appeared in Reviews of Infectious Diseases in 1979, volume 1, pages 701–719. Its PubMed record explicitly identifies the 1897 German original: 1979 is the English republication date, not the discovery date (English republication record — PubMed 🔗).

From Bacillus botulinus to Clostridium botulinum

Section titled “From Bacillus botulinus to Clostridium botulinum”

The name comes from botulus, the Latin word for sausage, reflecting botulism’s earlier association with sausage poisoning. It does not describe the bacterium’s shape, and the Ellezelles food was ham rather than sausage (Historical notes on botulism — Movement Disorders 🔗). LPSN lists the modern combination as Clostridium botulinum (van Ermengem 1896) Bergey et al. 1923, preserving van Ermengem’s name in the scientific attribution (Clostridium botulinum nomenclature record — LPSN 🔗).

Later work showed that botulism involved more than one bacterial strain or toxin type. The Ellezelles organism is described retrospectively as nonproteolytic—meaning it does not break down proteins in the way proteolytic strains do—and associated with type B toxin. The type A/type B distinction came from later research; van Ermengem did not establish the modern serotype classification himself (Botulinum neurotoxin-producing bacteria — mBio 🔗).

The historical name therefore should not imply one uniform organism or one toxin. Modern CDC guidance also recognizes that related bacteria, including Clostridium butyricum and Clostridium baratii, can produce botulinum toxin (About botulism — CDC 🔗).

Justinus Kerner described the clinical syndrome and proposed a possible therapeutic use for the responsible substance. Van Ermengem established its bacterial and toxin origin. Schantz contributed to purified-toxin research, and Scott developed the therapeutic Oculinum / Botox pathway. These contributions answer different versions of the word “discovery” (Historical notes on botulism and therapeutic toxin use — Movement Disorders 🔗).

Scott’s own 1980 publication concerns botulinum toxin injections for strabismus, an eye-alignment disorder, rather than the discovery of the organism (Botulinum toxin injection into extraocular muscles — Journal of Pediatric Ophthalmology & Strabismus 🔗).

Van Ermengem belongs in foundational microbiology and botulism history. His work explains the difference between botulism as a disease, a toxin-producing bacterium, the botulinum neurotoxin family, and regulated pharmaceutical products.

The Ellezelles strain’s type B association also should not be read as the product identity of Botox, which contains a type A toxin. Its prescribing information defines a specific preparation and assay, with potency units that cannot be converted into those of other products (Botox prescribing information, sections 5.2 and 11 — AbbVie 🔗). Type A versus type B explains the biological distinction; a shared place in toxin history does not establish clinical interchangeability.

1. A history describes van Ermengem as the inventor of Botox. Which revision best reflects his contribution?
2. A database dates the English version of van Ermengem’s paper to 1979. How should that date be interpreted?
3. What does calling the Ellezelles illness foodborne intoxication mean?